Global Bioactive Glass Market 2017-2021
About Bioactive Glass
Bioactive glass is a surface-reactive glass-ceramic biomaterial. The biocompatibility and bioactivity of these glasses have led to it being used as an implant in the human body, especially to repair and replace diseased or damaged bones. Bioactive glass is an important category of bioactive materials with a wide range of applications in tissue repair materials which are majorly used for surgical procedures. These are composed of silicon, calcium, sodium, and phosphorus. Bioactive glasses are available in various forms such as powders, nano-powders, and granules.
Technavio’s analysts forecast the global bioactive glass market to grow at a CAGR of 14.39% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global bioactive glass market for 2017-2021. To calculate the market size, the report considers the revenues generated from the sales of various applications of bioactive glass are considered.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Bioactive Glass Market 2017-2021
Technavio recognizes the following companies as the key players in the global bioactive glass market: Arthrex, Biomet, NORAKER, SCHOTT, and Stryker
Other Prominent Vendors in the market are: BonAlive Biomaterials, British Glass Manufacturers' Confederation, Mo-Sci Corporation, OW Warehouse, and LASAK.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Mergers and acquisitions. Mergers and acquisitions (M&A) are a common market growth-promoting strategy adopted by players. Companies acquire or merge with other companies to increase their market share or to expand their business model. Hence, recently, many top companies have acquired smaller ones to extend their product base. For instance, Bio-met has acquired two major companies: Novabone in early 2017 and Zimmer in 2015. These acquisitions have led to an increase in the revenue and the expansion of product portfolio. It is expected that many other companies might enter into M&A during the forecast period. This trend will tighten the competition in the market and improve the product standards.”
According to the report, one of the major drivers for this market is Growing clinical application of bioactive glass. Bioactive glass is made from compounds of calcium oxide, silicon oxide, and phosphorus oxide. It resembles the physical appearance of powdered glass. It is called bioactive since it can be used in surgeries safely, as opposed to other biomedical products that are inert. Bioactive glass is hard, and hence, can replace some of the inert glass fillers mixed with polymers to make composite tooth fillings. The global dental consumables market is expected to grow at a CAGR of more than 6% during the forecast period. This will bring about more demand for bioactive glass, especially in tooth filling applications.
Further, the report states that one of the major factors hindering the growth of this market is Heavy investments in terms of technology. In the medical field, bioactive glass is used in rapid prototyping technology, and the market for rapid prototyping technology is regularly affected due to high investment cost and increase in medical expenditure. Bioactive glass is used in rapid prototyping technology, which is more expensive than any other medical surgeries. The price for this technology varies with respect to the different surgeries where bioactive glass is used. This will be one of the major challenges for the market as medical expenditure for bioactive glass is likely to soar during the forecast period.
Arthrex, Biomet, NORAKER, SCHOTT, Stryker, BonAlive Biomaterials, British Glass Manufacturers' Confederation, Mo-Sci Corporation, OW Warehouse, and LASAK.